TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,648 | -65.5% | 61,800 | +2.5% | 0.02% | -64.7% |
| Q2 2023 | $1,497,852 | +52.5% | 60,300 | -7.7% | 0.07% | +44.7% |
| Q1 2023 | $982,112 | +20.7% | 65,300 | -5.1% | 0.05% | +4.4% |
| Q4 2022 | $813,904 | +317.4% | 68,800 | +109.1% | 0.04% | +275.0% |
| Q3 2022 | $195,000 | +9.6% | 32,900 | -21.7% | 0.01% | +9.1% |
| Q2 2022 | $178,000 | +9.2% | 42,000 | +145.6% | 0.01% | +37.5% |
| Q1 2022 | $163,000 | -63.6% | 17,100 | -27.5% | 0.01% | -66.7% |
| Q4 2021 | $448,000 | -23.9% | 23,600 | +33.3% | 0.02% | -29.4% |
| Q3 2021 | $589,000 | +390.8% | 17,700 | +608.0% | 0.03% | +580.0% |
| Q1 2021 | $120,000 | +15.4% | 2,500 | +25.0% | 0.01% | 0.0% |
| Q4 2020 | $104,000 | +300.0% | 2,000 | +100.0% | 0.01% | +150.0% |
| Q3 2020 | $26,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |